#China #Xi'an #Veterinary Diagnostics #KHB Group #FOCUS PEGASUS MF200

KHB Unveils the Enhanced FOCUS PEGASUS MF200 for Veterinary Diagnostics

The ever-evolving field of veterinary diagnostics has recently witnessed a significant advancement with the introduction of the enhanced FOCUS PEGASUS MF200, a state-of-the-art Automatic Multifunctional Veterinary Analyzer by Guangzhou Focus Biotechnology Co., Ltd., a subsidiary of KHB Group. This latest innovation is set to revolutionize the efficiency, reliability, and accessibility of diagnostics in veterinary practices.

A Leap in Diagnostic Technology

The FOCUS PEGASUS MF200 represents a comprehensive solution that integrates various testing modalities including biochemistry, electrolytes, coagulation, and immunofluorescence into a single, compact device. Designed for veterinarians, this analyzer addresses modern diagnostic needs with smart point-of-care testing (POCT) solutions. Here are the major features that make the MF200 stand out:

• - 4-in-1 Testing Capability: This multifunctional analyzer can perform a variety of tests including biochemistry, electrolytes, coagulation, and immunofluorescence tests, greatly simplifying the workload for veterinarians by enabling multiple test types to be conducted with just one device.
• - Simplified Operation: With a single-step operation, veterinarians can obtain results in as little as 10 minutes, significantly reducing wait times for critical diagnostic information. This efficiency allows practitioners to focus on treatment rather than testing delays.
• - Extensive Test Coverage: The MF200 covers over 90% of routine diagnostics for pets, ensuring that veterinary practices can meet a wide range of diagnostic needs with a single unit.
• - User-Friendly Design: The system requires only a small sample size (less than 100 μL), minimizing stress for pets during sample collection. This pet-friendly design is critical in promoting a positive experience for both animals and their owners.
• - Intelligent Features: The device automates several processes, including sample dilution, centrifugation, and QR code scanning, reducing the possibility of human error and ensuring consistent accuracy. This automation enhances user-friendliness and reliability in results.

Enhancing Veterinary Operations

The MF200 is not just about advanced technology; it's a tool that helps veterinarians improve their daily operations. Its intuitive interface, streamlined procedures, and customizable reports elevate diagnostic efficiency, ultimately benefitting both the practitioner and the pet patients. Following successful product demonstrations in Asia and North America, the enhanced MF200 will be showcased at MEDICA 2025, reinforcing KHB's commitment to advancing intelligent, efficient, and pet-friendly veterinary diagnostics.

Li Ming, CEO of KHB Group, stated, "The MF200 represents the next evolution in intelligent veterinary medicine. It is a compact solution that redefines diagnostic efficiency from the ground up. Our goal is to empower veterinarians to work quickly and reliably, with confidence in every result."

About KHB Group

Shanghai Kehua Bio-engineering Co., Ltd. (KHB), listed on the Shenzhen Stock Exchange (SZSE) under the code 002022.SZ, is a pioneering IVD (In Vitro Diagnostics) company offering a comprehensive range of medical diagnostic products. With a focus on immunodiagnostics, biochemical diagnostics, molecular diagnostics, and point-of-care testing, KHB has established itself as a high-tech entity since its inception in 1981.

In 2023, KHB launched Guangzhou Focus Biotechnology Co., Ltd. to specialize in veterinary POCT solutions, aiming to become a global leader in animal health diagnostics. For more information, visit KHB’s official website and follow them on LinkedIn, Facebook, and Twitter. For inquiries regarding products or corporate information, please reach out to [email protected].